Intracerebral hemorrhage causes: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Intracerebral hemorrhage}} {{CMG}}; {{AE}} {{SaraM}} ==Overview== ==Causes== ==References== {{reflist|2}} Category:Neurology Category:Cardiology Ca..." |
No edit summary |
||
| Line 7: | Line 7: | ||
==Causes== | ==Causes== | ||
The two major causes of [[intracerebral hemorrhage]] include:<ref name="pmid22858729">{{cite journal| author=Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi E, Mustanoja S et al.| title=SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. | journal=Stroke | year= 2012 | volume= 43 | issue= 10 | pages= 2592-7 | pmid=22858729 | doi=10.1161/STROKEAHA.112.661603 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22858729 }} </ref><ref name=Hart> Hart, Robert G., Bradley S. Boop, and David C. Anderson. "Oral anticoagulants and intracranial hemorrhage facts and hypotheses." Stroke 26.8 (1995): 1471-1477.</ref><ref name=Knudsen> Knudsen, Katherine A., et al. "Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria." Neurology 56.4 (2001): 537-539. </ref><ref name=Lovelock>Lovelock, C. E., A. J. Molyneux, and P. M. Rothwell. "Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study." The Lancet Neurology 6.6 (2007): 487-493. </ref><ref name="pmid1117973">{{cite journal| author=Rümke CL| title=Letter: Implications of the statement: No side effects were observed. | journal=N Engl J Med | year= 1975 | volume= 292 | issue= 7 | pages= 372-3 | pmid=1117973 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1117973 }} </ref> | |||
* [[hypertension|Long-standing hypertension]] | |||
**Hypertensive vasculopathy | |||
* [[Cerebral amyloid angiopathy]] | |||
Other causes of [[intracerebral hemorrhage]] include:<ref name="pmid22858729">{{cite journal| author=Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi E, Mustanoja S et al.| title=SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. | journal=Stroke | year= 2012 | volume= 43 | issue= 10 | pages= 2592-7 | pmid=22858729 | doi=10.1161/STROKEAHA.112.661603 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22858729 }} </ref><ref name=Hart> Hart, Robert G., Bradley S. Boop, and David C. Anderson. "Oral anticoagulants and intracranial hemorrhage facts and hypotheses." Stroke 26.8 (1995): 1471-1477.</ref><ref name=Knudsen> Knudsen, Katherine A., et al. "Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria." Neurology 56.4 (2001): 537-539. </ref><ref name=Lovelock>Lovelock, C. E., A. J. Molyneux, and P. M. Rothwell. "Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study." The Lancet Neurology 6.6 (2007): 487-493. </ref><ref name="pmid1117973">{{cite journal| author=Rümke CL| title=Letter: Implications of the statement: No side effects were observed. | journal=N Engl J Med | year= 1975 | volume= 292 | issue= 7 | pages= 372-3 | pmid=1117973 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1117973 }} </ref> | |||
* Vascular malformations | |||
** [[Arteriovenous malformation|Arteriovenous malformations (AVMs)]] | |||
** [[Aneurysms]] | |||
* Drugs | |||
**[[cocaine]] | |||
**[[Amphetamines]] | |||
* [[Vasculitis]] | |||
* Bleeding disorders | |||
** [[Liver disease]] | |||
** Anticoagulant medication | |||
** [[Thrombolytic therapy]] | |||
* [[Tumor|Brain tumor]] | |||
* Hemorrhagic transformation of an ischemic stroke | |||
* [[Moyamoya disease]] | |||
* [[Tumor|Tumors]] | |||
* [[Central nervous system|Central nervous system (CNS)]] infection | |||
** [[Encephalitis]] | |||
** [[Herpes simplex]] | |||
==References== | ==References== | ||
Revision as of 18:14, 23 November 2016
|
Intracerebral hemorrhage Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
AHA/ASA Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2015) |
|
AHA/ASA Guideline Recommendation for the Primary Prevention of Stroke (2014) |
|
Case Studies |
|
Intracerebral hemorrhage causes On the Web |
|
American Roentgen Ray Society Images of Intracerebral hemorrhage causes |
|
Risk calculators and risk factors for Intracerebral hemorrhage causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Causes
The two major causes of intracerebral hemorrhage include:[1][2][3][4][5]
- Long-standing hypertension
- Hypertensive vasculopathy
- Cerebral amyloid angiopathy
Other causes of intracerebral hemorrhage include:[1][2][3][4][5]
- Vascular malformations
- Drugs
- Vasculitis
- Bleeding disorders
- Liver disease
- Anticoagulant medication
- Thrombolytic therapy
- Brain tumor
- Hemorrhagic transformation of an ischemic stroke
- Moyamoya disease
- Tumors
- Central nervous system (CNS) infection
References
- ↑ 1.0 1.1 Meretoja A, Strbian D, Putaala J, Curtze S, Haapaniemi E, Mustanoja S; et al. (2012). "SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage". Stroke. 43 (10): 2592–7. doi:10.1161/STROKEAHA.112.661603. PMID 22858729.
- ↑ 2.0 2.1 Hart, Robert G., Bradley S. Boop, and David C. Anderson. "Oral anticoagulants and intracranial hemorrhage facts and hypotheses." Stroke 26.8 (1995): 1471-1477.
- ↑ 3.0 3.1 Knudsen, Katherine A., et al. "Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria." Neurology 56.4 (2001): 537-539.
- ↑ 4.0 4.1 Lovelock, C. E., A. J. Molyneux, and P. M. Rothwell. "Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study." The Lancet Neurology 6.6 (2007): 487-493.
- ↑ 5.0 5.1 Rümke CL (1975). "Letter: Implications of the statement: No side effects were observed". N Engl J Med. 292 (7): 372–3. PMID 1117973.